Canada markets close in 19 minutes

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.70+0.33 (+3.52%)
At close: 04:00PM EDT
9.63 -0.07 (-0.72%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.31B
Enterprise Value 2.06B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)46.95
Price/Book (mrq)5.75
Enterprise Value/Revenue 45.54
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 312.92%
S&P500 52-Week Change 325.69%
52 Week High 316.75
52 Week Low 34.97
50-Day Moving Average 38.70
200-Day Moving Average 38.92

Share Statistics

Avg Vol (3 month) 34.65M
Avg Vol (10 day) 33.83M
Shares Outstanding 5230.27M
Implied Shares Outstanding 6239.05M
Float 8191.96M
% Held by Insiders 15.20%
% Held by Institutions 197.21%
Shares Short (May 15, 2024) 442.37M
Short Ratio (May 15, 2024) 48.27
Short % of Float (May 15, 2024) 426.88%
Short % of Shares Outstanding (May 15, 2024) 417.83%
Shares Short (prior month Apr 15, 2024) 438.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-697.64%

Management Effectiveness

Return on Assets (ttm)-39.82%
Return on Equity (ttm)-85.19%

Income Statement

Revenue (ttm)46.23M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)13.70%
Gross Profit (ttm)N/A
EBITDA -349.54M
Net Income Avi to Common (ttm)-354.11M
Diluted EPS (ttm)-1.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)296.33M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)50.97M
Total Debt/Equity (mrq)12.71%
Current Ratio (mrq)4.65
Book Value Per Share (mrq)1.69

Cash Flow Statement

Operating Cash Flow (ttm)-316.76M
Levered Free Cash Flow (ttm)-208.61M